OTC Markets EXMKT - Delayed Quote USD
Eloxx Pharmaceuticals, Inc. (ELOX)
0.0001
0.0000
(0.00%)
At close: April 23 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 182.88k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| RUBIN STEVEN DANIEL Director | -- | Direct | -- | Jan 24, 2025 |
| AGGARWAL SUMIT Director | -- | Direct | -- | Jan 24, 2025 |
| WALTS ALAN EDMUND PH.D. Director | -- | Direct | -- | Jan 24, 2025 |
| ANDROSKI LINDSAY J.D. Director | -- | Direct | -- | Jan 24, 2025 |
| RUBIN STEVEN DANIEL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 16, 2024 |
| AGGARWAL SUMIT Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 16, 2024 |
| WALTS ALAN EDMUND PH.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 16, 2024 |
| ANDROSKI LINDSAY J.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 16, 2024 |
| AGGARWAL SUMIT Chief Executive Officer | -- | Direct | -- | Dec 1, 2021 |
| MODUR VIJAY M.D., PH.D. Officer | -- | Direct | -- | Dec 1, 2021 |
| WALTS ALAN EDMUND PH.D. Director | -- | Direct | -- | Dec 1, 2021 |
| GEFFKEN DANIEL E Chief Financial Officer | Purchase at price 0.72 per share. | Direct | 36,000 | Nov 29, 2021 |
| BELLOFF NEIL S. Chief Operating Officer | -- | Direct | -- | Jul 30, 2021 |
| BELLOFF NEIL S. Chief Operating Officer | -- | Direct | -- | May 25, 2021 |
| KARIV TOMER Director | Purchase at price 1.70 per share. | Indirect | 10,074,072 | May 13, 2021 |
| PAREKH RAJESH R Director | Purchase at price 1.70 per share. | Indirect | 4,193,332 | May 13, 2021 |
| NUSSBAUM RAN Director | Purchase at price 1.70 per share. | Indirect | 10,074,072 | May 13, 2021 |
| PONTIFAX MANAGEMENT 4 G.P. 2015, LTD. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.70 per share. | Indirect | 10,074,072 | May 13, 2021 |
| BELLOFF NEIL S. Chief Operating Officer | -- | Direct | -- | Apr 30, 2021 |
| PAREKH RAJESH R Director | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Apr 1, 2021 |
| BELLOFF NEIL S. Chief Operating Officer | -- | Direct | -- | Feb 25, 2021 |
| WILLIAMS GREGORY C Chief Executive Officer | -- | Direct | -- | Feb 25, 2021 |
| BELLOFF NEIL S. Chief Operating Officer | -- | Direct | -- | Jan 29, 2021 |
| WILLIAMS GREGORY C Chief Executive Officer | -- | Direct | -- | Jan 29, 2021 |
| BELLOFF NEIL S. Chief Operating Officer | -- | Direct | -- | Oct 30, 2020 |
| WILLIAMS GREGORY C Chief Executive Officer | -- | Direct | -- | Oct 30, 2020 |
| BELLOFF NEIL S. Chief Operating Officer | -- | Direct | -- | Jul 30, 2020 |
| WILLIAMS GREGORY C Chief Executive Officer | -- | Direct | -- | Jul 30, 2020 |
| BELLOFF NEIL S. Chief Operating Officer | -- | Direct | -- | Apr 30, 2020 |
| WILLIAMS GREGORY C Chief Executive Officer | -- | Direct | -- | Apr 30, 2020 |
| WEAVER GREGORY L Former | -- | Direct | -- | Mar 13, 2020 |
| WARD ROBERT E Former | -- | Direct | -- | Feb 28, 2020 |
| SNOW DAVID P Former | -- | Direct | -- | Feb 28, 2020 |
| BELLOFF NEIL S. General Counsel | -- | Direct | -- | Jan 30, 2020 |
| BELLOFF NEIL S. Chief Operating Officer | -- | Direct | -- | Jan 30, 2020 |
| WEAVER GREGORY L Chief Financial Officer | -- | Direct | -- | Jan 30, 2020 |
| WEAVER GREGORY L Chief Financial Officer | -- | Direct | -- | Jan 30, 2020 |
| WILLIAMS GREGORY C Chief Operating Officer | -- | Direct | -- | Jan 30, 2020 |
| WILLIAMS GREGORY C Chief Executive Officer | -- | Direct | -- | Jan 30, 2020 |
| SNOW DAVID P Officer | -- | Direct | -- | Jan 30, 2020 |
| SNOW DAVID P Former | -- | Direct | -- | Jan 30, 2020 |
| WARD ROBERT E Chief Executive Officer | -- | Direct | -- | Dec 26, 2019 |
| WARD ROBERT E Chief Executive Officer | -- | Direct | -- | Sep 26, 2019 |
| WARD ROBERT E Chief Executive Officer | -- | Direct | -- | Jun 26, 2019 |
| KARIV TOMER Director | Purchase at price 9.00 per share. | Indirect | 1,800,000 | Jun 24, 2019 |
| NUSSBAUM RAN Director | Purchase at price 9.00 per share. | Indirect | 1,800,000 | Jun 24, 2019 |
| PONTIFAX MANAGEMENT 4 G.P. 2015, LTD. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 9.00 per share. | Indirect | 1,800,000 | Jun 24, 2019 |
| WARD ROBERT E Chief Executive Officer | -- | Direct | -- | Mar 26, 2019 |
| WARD ROBERT E Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 28, 2018 |
| WARD ROBERT E Chief Executive Officer | -- | Direct | -- | Dec 26, 2018 |
Related Tickers
EVLO Evelo Biosciences, Inc.
0.0005
0.00%
KPRX Kiora Pharmaceuticals, Inc.
3.1200
+1.96%
PMVP PMV Pharmaceuticals, Inc.
1.0700
-0.93%
MIR.V MedMira Inc.
0.0900
0.00%
KZR Kezar Life Sciences, Inc.
4.5800
+1.78%
VTVT vTv Therapeutics Inc.
20.55
+3.32%
NKGN NKGen Biotech, Inc.
0.1223
+9.29%
MRKR Marker Therapeutics, Inc.
1.1700
-1.68%
IGC IGC Pharma, Inc.
0.2940
+2.80%
ENZC Enzolytics, Inc.
0.0006
-14.29%